Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Avadel Pharmaceuticals (AVDL) Ownership - Who Owns Avadel Pharmaceuticals?
633 Followers
Avadel Pharmaceuticals (AVDL) Ownership Overview
14.51% Insiders
5.36% Mutual Funds
7.59% Other Institutional Investors
72.54% Public Companies and
Individual Investors
The ownership structure of Avadel Pharmaceuticals (AVDL) stock is a mix of institutional, retail and individual investors. Approximately 12.95% of the company’s stock is owned by Institutional Investors, 14.51% is owned by Insiders and 72.54% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 16, 2024 | xxxxxxxxxxxxx | $29000 | |
| Aug 15, 2023 | Mark Anthony Mccamish Director | xxxxxxxxxxxxx | $432597 |
| Aug 14, 2023 | xxxxxxxxxxxxx | $28900 | |
| Aug 11, 2023 | Geoffrey Michael Glass Director | xxxxxxxxxxxxx | $187600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $820212 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $8030130 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $24696980 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $25343850 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,083,728 | Institution | 4.24% | 67,259,000 | |
| 3,444,676 | Institution | 3.58% | 56,733,814 | |
| 3,418,703 | Institution | 3.55% | 56,306,038 | |
| 1,500,524 | Institution | 1.56% | 24,713,630 | |
| 1,462,225 | Institution | 1.52% | 24,082,846 | |
| 475,437 | Institution | 0.49% | 7,830,447 | |
| 318,564 | Institution | 0.33% | 5,246,749 | |
| 300,000 | Institution | 0.31% | 4,941,000 | |
| 261,009 | Institution | 0.27% | 4,298,818 | |
| 126,776 | Institution | 0.13% | 2,088,001 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,083,728 | Institution | 4.24% | 67,259,000 | |
| 318,564 | Institution | 0.33% | 5,246,749 | |
| 300,000 | Institution | 0.31% | 4,941,000 | |
| 261,009 | Institution | 0.27% | 4,298,818 | |
| 85,516 | Institution | 0.09% | 1,408,449 | |
| 77,165 | Institution | 0.08% | 1,270,908 | |
| 54,468 | Institution | 0.06% | 897,088 | |
| 7,028 | Institution | <0.01% | 115,751 | |
| 6,859 | Institution | <0.01% | 112,968 | |
| 1,800 | Institution | <0.01% | 29,646 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,982,600 | Institution | 3.10% | 41,935,356 | |
| 2,449,191 | Institution | 2.55% | 40,338,176 | |
| 826,197 | Institution | 0.86% | 13,607,465 | |
| 344,082 | Institution | 0.36% | 4,837,793 | |
| 85,517 | Institution | 0.09% | 1,202,369 | |
| 54,860 | Institution | 0.06% | 888,732 | |
| 53,686 | Institution | 0.06% | 855,755 | |
| 38,348 | Institution | 0.04% | 621,238 | |
| 37,926 | Institution | 0.04% | 604,920 | |
| 33,099 | Institution | 0.03% | 536,204 |
FAQ
Who Owns Avadel Pharmaceuticals (AVDL)?
According to the latest TipRanks data, approximately 7.59% of the company's stock is held by institutional investors, 14.51% is held by insiders, and 72.54% is held by retail investors.
What percentage of Avadel Pharmaceuticals (AVDL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.59% of Avadel Pharmaceuticals (AVDL) stock is held by institutional investors.
What percentage of Avadel Pharmaceuticals (AVDL) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.54% of Avadel Pharmaceuticals (AVDL) stock is held by retail investors.
Who owns the most shares of Avadel Pharmaceuticals (AVDL)?
JANUS INVESTMENT FUND owns the most shares of Avadel Pharmaceuticals (AVDL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.